The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Treating patients with multiple myeloma in Ireland
Philip Murphy, MD, Beaumont Hospital, Dublin, Ireland, highlights the advances in treatment for multiple myeloma in recent years and the current treatment landscape for patients in Ireland who are newly diagnosed and those with relapsed/refractory (R/R) disease. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
